The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Fortress Diagnostics, Lemaitre Vascular, MedPAC.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Color, Labcorp, Rapid Medical, Stratus Medical, Zebra Medical.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atox, Bruker, Cell and Gene Therapy Catapult, Cpi, Healthimation, Masimo, Microfluidx, Nanthealth, Nemaura, OpenNMS, Orcam, Perimeter Medical Imaging, Telix Japan, Transenterix, Wishbone Medical.

Moderna Inc. dosed the first of what could be as many as 30,000 healthy volunteers Monday morning as it began its phase III COVID-19 vaccine trial.

A quick look back at top stories.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Beigene, Can-Fite, Carisma, Celltrion, Checkmate, Diffusion, Eton, Generex, Gilead, Kite, Kyowa, Merus, Neoimmunetech, Ocugen, Oculis, Pharmacyte, Scpharmaceuticals, Solid.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amag, Amyris, Anacura Group, Astrazeneca, Axoprotego, Biocomo, Boehringer, Centogene, Cerevel, Cyclica, Clearside, Elevar, Eli Lilly, Emergent, Envisionrx, Farmacore, Heat, Immodulon, LGM, Lynk, Medicinova, Nexgen, Novartis, Oasmia, Onconova, Palatin, PDS, Pfizer, Redhill, Rite Aid, Sandoz, Tanner, Tvardi, Venatorx, Zentalis.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Aerie, AI Therapeutics, Amarin, Dalcor, Dare, Destiny, Eyepoint, Immunic, Jcyte, Moderna, NGM, Opthea, Promab, Puma, Rezolute, Rigel, TCR2.